Recbio AGM: Shareholders Endorse 2025 Accounts, 2026 Budget and Seven Other Resolutions with 99.99% Approval

Bulletin Express05-28

Jiangsu Recbio Technology Co., Ltd. (Recbio) secured near-unanimous shareholder support for all eight ordinary resolutions tabled at its Annual General Meeting (AGM) held on 28 May 2026 in Taizhou, Jiangsu Province.

A total of 319.64 million shares—representing 51.05% of the company’s 626.08 million issued shares—were voted at the meeting. Each resolution received at least 99.99% of the votes cast in favour, with opposition limited to 4,500 votes (0.0014%) per item and negligible abstentions.

Key approvals included: • 2025 Financial Accounts Report. • 2026 Financial Budget Report. • 2025 Board Work Report and 2025 Annual Report. • Appointment of auditors for 2026. • 2026 remuneration scheme for directors. • 2025 profit distribution plan. • Proposed change in the use of proceeds.

All directors were in attendance. Voting was conducted by poll, with Computershare Hong Kong Investor Services Limited and two shareholder representatives acting as scrutineers. The meeting complied with the Company Law of the PRC, Hong Kong Listing Rules and Recbio’s Articles of Association.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment